Charles River Laboratories (Massachusetts) Receives FDA Approval For Sale And Marketing Of First Portable Endotoxin Test System, The Endosafe-PTS(TM)

WILMINGTON, Mass.--(BUSINESS WIRE)--July 18, 2006--Charles River Laboratories International, Inc. (NYSE:CRL - News) has received FDA approval that allows for the sale and marketing of the first portable endotoxin test system, the Endosafe-PTS(TM). The patented Endosafe-PTS(TM) is used to detect endotoxin contaminants in drugs, medical devices, biological products and other unique applications including NASA spacecraft missions. The PTS is a revolutionary technology that: is a portable handheld system that can be used for point of use testing, provides quantitative results in 15 minutes rather than current methods which take from 45 minutes to several days, requires minimal technical training - just insert the PTS cartridge, add sample and read quantitative results.
MORE ON THIS TOPIC